Butterfly Network Enters Bladder Scanning Market With iQ+ Bladder

With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology.The bundled bladder solution
  • With iQ+ Bladder, Butterfly expands outside its core point-of-care ultrasound market to better serve the bladder scanning market with its proprietary Ultrasound-on-Chip™ technology.
  • The bundled bladder solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly.

Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today introduced its first specialty product, iQ+ Bladder™, now available for purchase in the United States. The bundled solution includes an iQ+ Bladder probe, streamlined software, compact rolling cart, tablet and power splitter, paired with premium assembly. Combined, the solution offers a fit-for-purpose ultrasound-based bladder scanner that helps nurses get automated bladder volume calculations, with 3D visualizations, in seconds.

Total
0
Shares
Related Posts
Read More

VBI Vaccines Inc. Announces The Borrowers And The Lenders Have Agreed To Extend The Forbearance Period Until January 23, 2024, If Conditions Not Met, The Period Will Be Terminated And K2 HealthVentures LLC May Declare An Event Of Default

 As previously disclosed, on November 13, 2023, VBI Vaccines Inc. (the "Company") along with its subsidiary VBI Cda (collectively, the "Borrowers") entered into a forbearance agreement (the "Forbearance Agreement")

VBIV